<p>Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding. </p>
Displaying 3701 - 3720 of 5650
CardSystems Solutions, Inc., and Solidus Networks, Inc., d/b/a Pay By Touch Solutions, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
052 3148
Xanga.com, Inc., John Hiler, and Marc Ginsburg
Type of Action
Federal
Last Updated
FTC Matter/File Number
062-3073
Austin Board of Realtors., In the Matter of
The Commission entered into a final consent order settling charges against the Austin Board of Realtors (ABOR) for its practice of preventing consumers with listing agreements for potentially low-cost, unbundled brokerage services from marketing their listings on public real estate-related Internet sites. In settling the charges, ABOR is prohibited from adopting or enforcing any rule that treats one type of real estate listing agreement more advantageously than any other, or from interfering with its members ability to enter into any lawful listing agreement with home sellers.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0510219
Docket Number
C-4167
Job Resources, Inc., and Jeffrey Charles Lord
Type of Action
Federal
Last Updated
FTC Matter/File Number
052-3053
Puerto Rico Association of Endodontists, Corp., In the Matter of
The Commission approved a final consent order settling charges alleging that thirty competing association members acted unlawfully by agreeing to set the prices they would charge dental insurance plans, and by refusing to deal with plans that would not accept the collectively determined prices.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0510170
International Research and Development Corporation of Nevada, et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
042-3138
Sagee U.S.A. Group, Inc., et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
032-3140
Hologic Inc., In the Matter of
The Commission approved a final consent order to ensure the maintenance of competition in the market for prone stereotactic breast biopsy systems (SBBSs). The Commission had challenged this merger which was consummated in 2005. The order required the divestiture of all prone SBBS assets to Siemens, a company well-positioned to become a competitor in this market.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0510263
Walsh Optical, Inc., a corporation, and Kevin Walsh, individually and as an officer of the corporation, FTC.
Type of Action
Federal
Last Updated
FTC Matter/File Number
052 3184
Boston Scientific Corporation and Guidant Corporation, In the Matter of
The consent order settles charges that the $27 billion acquisition of Guidant Corporation by Boston Scientific Corporation would harm competition and consumers in several significant medical device markets. Guidant Corporation by Boston Scientific Corporation are the largest market shareholders in several coronary medical device markets in the U.S., together accounting for 90% of the U.S. PTCA balloon catheter market and 85% of the U.S. coronary guidewire market.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610046
Take-Two Interactive Software, Inc., and Rockstar Games, Inc., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
052 3158
Docket Number
C-4162
Perrigo Company and Alpharma Inc., F.T.C.
The Commission authorized staff to file a complaint in federal district court charging that Alpharma, Inc. and Perrigo Company drove up the prices for over-the-counter store-brand children’s liquid ibuprofen through an agreement eliminating competition between the two firms and allowing Perrigo to raise its prices creating higher profits to then be shared between the firms. According to the complaint, while both Alpharma and Perrigo filed for U.S. Food and Drug Administration approval to sell a generic version of children’s liquid Motrin, Alpharma was eligible to sell its product at least six months before approval would be granted to Perrigo. The two companies entered into an agreement not to compete whereby Perrigo would sell the children’s liquid ibuprofen for seven years and Alpharma, while would not marketing a competing product, would receive an up-front payment and a royalty on Perrigo’s sales of the product. To settle the charges, Alpharma and Perrigo paid a total of $6.25 million in illegal profits and agreed not to enter into agreements not to compete when one party to the agreement is a first filer of an abbreviated new drug application.
Type of Action
Federal
Last Updated
FTC Matter/File Number
0210197
Associated Octel Company Limited, The, In the Matter of
Associated Octel settled charges that its acquisition of Oboadler Company would eliminate direct competition and raise prices in the highly concentrated market for the manufacture and sale of lead antiknock compounds. Under terms of the order, Octel agreed to supply Oboadler's current distributor, Allchem Industries, Inc., with lead antiknock compounds for resale in the United States for 15 years.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
9910288
Docket Number
C-3913
Integrated Capital Inc., and Alan Wilson, Defendants, United States District Court, District of Nevad
Type of Action
Federal
Last Updated
Displaying 3701 - 3720 of 5650